What patent information shows up for Mounjaro (tirzepatide) in the FDA Orange Book?
The FDA’s Orange Book lists approved drugs and the associated patent or exclusivity claims. For Mounjaro (tirzepatide), you can use the Orange Book to see which patents are listed for the product, including the patent numbers and the “expiration” dates tied to those listings (plus any relevant exclusivity periods).
Because the Orange Book is dynamic (new listings and updates can be added as litigation or filings change), the most reliable approach is to look up Mounjaro directly in the FDA database and use the listed “SUBSTANCE” and “PRODUCT” entries for tirzepatide.
How long is Mounjaro’s patent protection / when does it expire?
Patent-related timelines in the Orange Book can be confusing because they include both:
- Patent “expiration” dates for the listed patents, and
- Separate exclusivity periods that may affect market entry even if a patent expires earlier.
To determine the exact “when does it expire” answer for Mounjaro, you’d check the Orange Book listings for tirzepatide and identify the latest relevant expiration date among the listed patents/exclusivity entries for the specific Mounjaro dosage forms.
Which patents are tied to tirzepatide (Mounjaro) listings?
Orange Book entries are listed under the approved active ingredient (tirzepatide) and the specific branded product(s). The patents shown there typically correspond to one or more of these categories:
- Composition-of-matter (drug substance)
- Formulation or specific delivery details
- Method-of-use (though not all method-of-use claims are listed in every way)
The Orange Book will show the exact patent numbers tied to the Mounjaro product listing, which is what matters for biosimilar/generic-style entry challenges.
Are there any known challenges or “workarounds” companies use before Orange Book expiry?
Companies looking to enter the market before a listed patent’s expiry may file patent certifications or otherwise challenge specific Orange Book-listed patents. If a patent is narrowed or invalidated, that can change when competitors can launch.
For a practical, competitor-focused view of the patent landscape around tirzepatide, DrugPatentWatch.com tracks patents and litigation signals; it can complement Orange Book checks:
- DrugPatentWatch.com (Mounjaro/tirzepatide): https://www.drugpatentwatch.com/p/ (search for “Mounjaro” or “tirzepatide” on the site)
How to pull the exact Orange Book “patent expiry” numbers yourself
Search the FDA Orange Book for:
1) Drug name: Mounjaro
2) Active ingredient: tirzepatide
3) Then review the “Patents and Exclusivity” table for the specific dosage form/product listing.
That table is where the official Orange Book patent numbers and expiration dates appear.
If you tell me your dosage, I can narrow the exact listing you need
Mounjaro has multiple strengths and package configurations. Orange Book listings can differ by product presentation. If you share the strength (e.g., 2.5 mg, 5 mg, 10 mg, etc.), I can tell you what to look for in the Orange Book entry that corresponds to that specific presentation.
Sources
- https://www.drugpatentwatch.com/